(Q51038604)

27 March 2018

title

Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. (English)

1 reference

27 March 2018

1 reference

Salma Rahimi

1

1 reference

27 March 2018

Zhiping Qian

2

1 reference

27 March 2018

Jodi Layton

3

1 reference

27 March 2018

Karen Fox-Talbot

4

1 reference

27 March 2018

William M Baldwin

5

1 reference

27 March 2018

Barbara A Wasowska

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

27 March 2018

American Journal of Transplantation

published in

1 reference

27 March 2018

volume

4

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

326-334

1 reference

27 March 2018

Effector mechanisms in allograft rejection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Complement-mediated regulation of tissue factor activity in endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Role of the C5b-9 complement complex in cell cycle and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

Effect of immunoglobulin variable region structure on C3b and C4b deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00334.X

10.1111/J.1600-6143.2004.00334.X

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018